Publisher Retracts Dozens of Studies

Springer Nature pulls 58 articles in one fell swoop, citing plagiarism and authorship manipulation, among other things.

Written byJoshua A. Krisch
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, PHILLIP WONGSpringer and BioMed Central today (November 1) announced the retraction of 58 articles across seven journals, affecting more than 200 authors. Springer Nature, the company behind both subsidiary publishers, issued the mass retraction notice upon discovering that some of the now-pulled papers’ authors had manipulated the peer review process, and that some of the reports contained plagiarism.

“We take every allegation seriously, and investigate every allegation of plagiarism,” a Springer Nature spokesperson told Retraction Watch. “In this case we identified irregularities which led us to suspect a broader pattern of manipulation.”

While most retractions are quiet, single-study affairs, in recent years publishers have issued an increasing number of mass retractions. In 2014, for instance, Springer and IEEE pulled more than 120 papers that had been produced by SciGen, a random study generator.

But the most recent cases of misconduct reported by Springer Nature were more difficult to detect. “A much more complex manipulation has taken place from a different group of authors,” the publisher’s spokesperson told Retraction Watch. “It involves complex manipulation of our submission and peer reviews systems.”

Tumor Biology and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform